Is OneMedNet Corporation (ONMD) a Buy, Sell, or Hold?
NASDAQ : ONMD
OneMedNet Corporation — News
$0.74 USD
$0.0 (-0.51%)
- Volume
- 51.86K
- Average Volume
- 972.21K
- Market Capitalization
- $42.14M
- P/E Ratio
- -15.26
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.22
- Year Low
- $0.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.27
| Source | Headline |
|---|---|
|
OneMedNet (NASDAQ:ONMD) Director Acquires $999,999.75 in Stock
OneMedNet Corporation (NASDAQ: ONMD - Get Free Report) Director Thomas Kosasa acquired 1,449,275 shares of the stock in a transaction that occurred on Thursday, July 30th. The stock was purchased at an average price of $0.69 per share, with a total value of $999,999.75. Following the completion of the transaction, the director owned 18,538,150 shares of defenseworld.net - 2026-08-10 04:23:15 |
|
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced it has entered into an agreement to supply its regulatory-grade, multi-modal imaging-centric iRWD™ platform data for use in the development and training of a foundational AI model. Under the terms of the agreement, OneMedNet will provide high-quality, de-identified, regulatory-grade healthcare data, including millions of medical imaging and associated clinical reports, with data delivery immediately. globenewswire.com - 2026-07-28 08:30:00 |
|
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced it has secured more than $3 million in new bookings to date for 2026 as of this announcement – surpassing the Company's total bookings for all of full-year 2025. The Company expects to recognize substantially all of these bookings as revenue by the end of the third quarter of 2026. globenewswire.com - 2026-06-10 09:00:00 |
|
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), today announced that its OneMedNet iRWD™ Network, has surpassed 90 million patient journeys and 270 million studies, with a healthcare partner network now exceeding 2,300 sites. The milestone represents direct progress against the strategic priorities the Company laid out to shareholders at the close of 2025, when OneMedNet identified expansion of its data network as a core pillar of long-term value creation. globenewswire.com - 2026-06-03 09:28:00 |
